Several organizations collaborate to create a standardized tool to screen allogeneic hematopoietic progenitor cell (HPC) donors for communicable disease risk factors in accordance with the requirements of the Food and Drug Administration (FDA), FACT, AABB, and the National Marrow Donor Program (NMDP). Both the HPC and cord blood questionnaires were recently revised to include recommendations made by the FDA’s Guidance for Industry: Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products, published this month.

When implementing the revised questionnaire and related materials, comply with established change control processes, including document control and personnel training. Changes made to the materials are listed in accompanying charts.

Download the Donor History Questionnaire for Allogeneic HPC, Apheresis and HPC, Marrow – Version 1.5 March 2016

Download the Donor History Questionnaire for HPC, Cord Blood – Version 1.2 March 2016

Ask FACT

FAQ

Ask a Peer
FACT Consulting

Accreditation Success Story

The Héma-Québec Public Cord Blood Bank (CBB) was created in 2004 to meet the needs of Quebecers and to contribute to the international effort towards a high-quality global inventory of cord blood units. Read more